» Articles » PMID: 15959652

Men's Decision-making About Predictive BRCA1/2 Testing: the Role of Family

Overview
Journal J Genet Couns
Publisher Wiley
Specialty Genetics
Date 2005 Jun 17
PMID 15959652
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Men who have a family history of breast and/or ovarian cancer may be offered a predictive genetic test to determine whether or not they carry the family specific BRCA1/2 mutation. Male carriers may be at increased risk of breast and prostate cancers. Relatively little is known about at-risk men's decision-making about BRCA1/2 testing. This qualitative study explores the influences on male patients' genetic test decisions. Twenty-nine in-depth interviews were undertaken with both carrier and noncarrier men and immediate family members (17 male patients, 8 female partners, and 4 adult children). These explored family members' experiences of cancer and genetic testing, decision-making about testing, family support, communication of test results within the family, risk perception and risk management. Implicit influences on men's testing decisions such as familial obligations are examined. The extent to which other family members--partners and adult children--were involved in testing decisions is also described. It is demonstrated that mothers of potential mutation carriers not only perceive themselves as having a right to be involved in making this decision, but also were perceived by their male partners as having a legitimate role to play in decision-making. There was evidence that (adult) children were excluded from the decision-making, and some expressed resentment about this. The implications of these findings for the practice of genetic counseling are discussed.

Citing Articles

Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing.

Tiller J, Bakshi A, Dowling G, Keogh L, McInerney-Leo A, Barlow-Stewart K Eur J Hum Genet. 2023; 32(3):286-294.

PMID: 37169978 PMC: 10923945. DOI: 10.1038/s41431-023-01373-1.


Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.

Perez L, Webster E, Bull L, Brewer J, Ahsan M, Lin J Gynecol Oncol. 2023; 173:106-113.

PMID: 37116391 PMC: 10650971. DOI: 10.1016/j.ygyno.2023.04.006.


Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.

Frey M, Ahsan M, Bergeron H, Lin J, Li X, Fowlkes R J Clin Oncol. 2022; 40(35):4129-4143.

PMID: 35960887 PMC: 9746789. DOI: 10.1200/JCO.22.00303.


Psychological Determinants of Men's Adherence to Cascade Screening for .

Ongaro G, Petrocchi S, Calvello M, Bonanni B, Feroce I, Pravettoni G Curr Oncol. 2022; 29(4):2490-2503.

PMID: 35448177 PMC: 9030516. DOI: 10.3390/curroncol29040203.


A randomized controlled trial comparing self-referred message to family-referred message promoting men's adherence to evidence-based guidelines on BRCA1/2 germline genetic testing: A registered study protocol.

Petrocchi S, Ongaro G, Calvello M, Feroce I, Bonanni B, Pravettoni G PLoS One. 2022; 17(4):e0266327.

PMID: 35395021 PMC: 8992988. DOI: 10.1371/journal.pone.0266327.


References
1.
Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B . Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev. 2000; 9(11):1251-4. View

2.
McAllister M, Evans D, Ormiston W, Daly P . Men in breast cancer families: a preliminary qualitative study of awareness and experience. J Med Genet. 1998; 35(9):739-44. PMC: 1051426. DOI: 10.1136/jmg.35.9.739. View

3.
Easton D, Ford D, Bishop D . Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet. 1995; 56(1):265-71. PMC: 1801337. View

4.
Van Riper M, McKinnon W . Genetic testing for breast and ovarian cancer susceptibility: a family experience. J Midwifery Womens Health. 2004; 49(3):210-9. DOI: 10.1016/j.jmwh.2004.01.021. View

5.
Bodd T, Reichelt J, Heimdal K, Moller P . Uptake of BRCA1 genetic testing in adult sisters and daughters of known mutation carriers in Norway. J Genet Couns. 2004; 12(5):405-17. DOI: 10.1023/a:1025864703405. View